Early Access Program of Telaprevir With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects

Condition:   Hepatitis CInterventions:   Drug: Telaprevir + peginterferon alfa + ribavirin;   Drug: peginterferon alfa + ribavirin;   Drug: peginterferon alfa + ribavirinSponsor:   Janssen-Cilag International NVAvailable - verified April 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials